Sep 30, 2011

Neurocrine Biosciences Q3 2011 Earnings Report

Total Revenue
$41.6M
Previous year: $14.4M
+188.2%
EPS
$0.57
Previous year: $0.07
+714.3%
Gross Profit
$41.6M
Previous year: $14.4M
+188.2%
Cash and Equivalents
$39.5M
Previous year: $77.3M
-48.9%
Free Cash Flow
$2.21M
Previous year: $1.06M
+109.5%
Total Assets
$149M

Neurocrine Biosciences

Neurocrine Biosciences